SAMM50 and cardiac hypertrophy: Samm50 significantly inhibited angiotensin II-induced autophagy activation, as manifested by decreased mitophagy protein levels; however, the inhibition of mitophagy by Vps34 inhibitor or PINK1 knockdown abolished the protective effect of Samm50 deficiency on cardiac hypertrophy.